Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
Go back to Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma| IMMTECH PHARMACEUTICALS, Inc. (NYSE: IMM) | Delayed: 0.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.28 | 52 Week High | $1.09 | |||
| Open | $0.28 | 52 Week Low | $0.06 | |||
| Day High | $0.28 | P/E | N/A | |||
| Day Low | $0.28 | EPS | $-0.33 | |||
| Volume | 19,750 | |||||
| Immtech Pharmaceuticals, Inc. (NASDAQ: IMMP) | Delayed: 0.39 +0.01 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $0.01 | |||
| Open | $0.38 | 52 Week Low | $0.00 | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $0.00 | |||
| Volume | 459,240 | |||||
